Abstract
Cytochrome P450 monooxygenases play a crucial role in the biosynthesis of many natural products and in the human metabolism of numerous pharmaceuticals. This has inspired synthetic organic and medicinal chemists to exploit them as catalysts in regio- and stereoselective CH-activating oxidation of structurally simple and complex organic compounds such as steroids. However, levels of regio- and stereoselectivity as well as activity are not routinely high enough for real applications. Protein engineering using rational design or directed evolution has helped in many respects, but simultaneous engineering of multiple catalytic traits such as activity, regioselectivity and stereoselectivity, while overcoming tradeoffs and diminishing returns, remains a challenge. Here we show that the exploitation of information derived from mutability landscapes and molecular dynamics simulations for rationally designing iterative saturation mutagenesis constitutes a viable directed evolution strategy. This combined approach ...
Original language | English |
---|---|
Pages (from-to) | 3395-3410 |
Number of pages | 16 |
Journal | ACS Catalysis |
Volume | 8 |
Issue number | 4 |
Early online date | 8 Mar 2018 |
DOIs | |
Publication status | Published - 6 Apr 2018 |
Keywords
- Directed evolution
- Cytochrome P450 monooxygenase
- Regioselectivity
- Stereoselectivity
- mutability landscapes
- iterative saturation mutagenesis
- Steroids
- C-H activation
Research Beacons, Institutes and Platforms
- Biotechnology
- Manchester Institute of Biotechnology